Akinsanya Karen 4
4 · Schrodinger, Inc. · Filed Feb 10, 2023
Insider Transaction Report
Form 4
Akinsanya Karen
President of R&D, Therapeutics
Transactions
- Award
Stock Option (right to buy)
2023-02-09+63,270→ 63,270 totalExercise: $23.29Exp: 2033-02-09→ Common Stock (63,270 underlying)
Footnotes (1)
- [F1]The option was granted on February 9, 2023. The shares underlying the option are scheduled to vest with respect to 25% of the shares on February 9, 2024 and the remainder are scheduled to vest in equal monthly installments through February 9, 2027.